IDV vehicle
36E79724D0015
ADALIMUMAB GROUP I, LINE ITEMS 1 AND 2 AND GROUP II LINE ITEMS 1 AND 2. AWARDED FOR A BASE YEAR OF 3/9/2024 TO 3/8/2025 PLUS FOUR ONE YEAR OPTION PERIODS.
Award details
Obligations, current value and potential value describe different measures; they are never added together.
| Field | Reported value |
|---|---|
| Agency | Department of Veterans Affairs |
| Office | NAC PHARMACEUTICALS (36E797) |
| NAICS | 325412 — Pharmaceutical Preparation Manufacturing |
| PSC | 6505 — Drugs and Biologicals |
| Parent award / vehicle | Not reported |
| Set-aside | NO SET ASIDE USED. |
| Pricing type | FIRM FIXED PRICE |
| Obligations | $0 |
| Current contract value | Not reported |
| Potential contract value / ceiling | $325.1M |
| Start date | Mar 9, 2024 |
| Current end date | Not available |
| Potential end date | Not available |
| Latest award activity | Sep 10, 2026 |
| Source loaded | Sep 26, 2026 |
Funding and modification history
Showing the latest 12 of 12 loaded transactions. Negative values are deobligations.
| Date | Modification | Obligation change | Description |
|---|---|---|---|
| Sep 10, 2026 | P00011 | $0 | MODIFICATION TO INCORPORATE CLAUSE 52.222-90, EXECUTIVE ORDER 14398, INTO THE CONTRACT. |
| Feb 6, 2026 | P00010 | $0 | EXERCISE OPTION YEAR TWO FOR ADALIMUMAB PEN/SYRINGE KITS WITH ORGANON LLC WITH PRICE CHANGES. |
| Jan 5, 2026 | P00009 | $0 | INCORPORATE THE 2026 SUBCONTRACTING PLAN |
| Dec 3, 2025 | P00008 | $0 | 2026 FEDERAL CEILING PRICES |
| May 20, 2025 | P00007 | $0 | UPDATE AUTHORIZED NEGOTIATOR FOR CONTRACT 36E79724D0015. |
| Feb 4, 2025 | P00006 | $0 | EXERCISE OPTION YEAR 1 FOR ADALIMUMAB PEN/SYRINGE KITS. PERIOD OF PERFORMANCE 3/9/2025 - 3/8/2026. |
| Jan 30, 2025 | P00005 | $0 | POC/AUTHORIZED NEGOTIATOR CHANGE |
| Jan 22, 2025 | P00004 | $0 | 2025 SUBCONTRACTING PLAN |
| Dec 3, 2024 | P00003 | $0 | 2025 PUBLIC LAW UPDATES |
| Mar 28, 2024 | P00002 | $0 | CRF SALES SUBMITTAL AND REPORTING CHANGES |
| Feb 23, 2024 | P00001 | $0 | POINT OF CONTACT CHANGES |
| Jan 9, 2024 | 0 | $0 | ADALIMUMAB GROUP I, LINE ITEMS 1 AND 2 AND GROUP II LINE ITEMS 1 AND 2. AWARDED FOR A BASE YEAR OF 3/9/2024 TO 3/8/2025 PLUS FOUR ONE YEAR OPTION PERIODS. |
Buyer contacts from matching notices
Matched on exact award/solicitation identifier and awarding agency. Source dates describe the notice, not current contact verification.
| Contact | Role | Published contact methods | Evidence | Source date |
|---|---|---|---|---|
| Christopher Carthron | Contract Specialist | Christopher.Carthron@va.gov | Source | Oct 20, 2023 |
| Christopher Carthron | Contract Specialist | Christopher.Carthron@va.gov | Source | Oct 12, 2023 |
| Chris Carthron | Contracting Officer | Christopher.Carthron@va.gov 708-786-4980 | Source | Sep 28, 2023 |
Research next steps
- Check the stated set-aside against the solicitation and current certifications.
- Review the award scope and buyer evidence before making a bid/no-bid decision.